

Pharmacovigilance & Regulatory Affairs Consulting in China
PV Solutions Limited provides consulting services to International pharmaceutical companies on pharmacovigilance and regulatory affairs in China.
Bilingual GVP and GCP audit readiness and local pharmacovigilance representation delivered by experts with decades of China regulatory experience.
Decades of compliance precision
20+
Years of local NMPA experience
100%
Audit readiness success rate
25+
Serve countries of pharma companies
Comprehensive risk mitigation
We bridge the gap between global pharmaceutical standards and local Chinese regulatory expectations.
China GVP/GCP Inspection & Audit
PV Strategy & Operations
Regulatory Intelligence
Meticulous pre-inspection audits and mock inspections designed to align your global protocols with local Chinese regulatory requirements.
Full-lifecycle pharmacovigilance system establishment, local RPPV/QPPV assignment, PSUR/PBRER, annual report, system files, and post-market surveillance strategies.
Real-time monitoring of NMPA policy shifts, providing actionable insights to keep your compliance framework ahead of changes.
